SCHEMBL4565341

SCHEMBL4565341

C=CCOS(C)(=O)=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4781363 0.79 CA2 (0.36)
SCHEMBL30711 0.79
SCHEMBL28129187 0.77
SCHEMBL15974796 0.77
SCHEMBL28129259 0.77
Fluoride SCHEMBL28105167 0.77
SCHEMBL28129188 0.77
Ammonia Solution, Strong SCHEMBL1743428 0.77
SCHEMBL28840612 0.77
SCHEMBL10752584 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117886999-A Preparation method and application of benzoxazine-olefin copolymer for deep well cementation 西南石油大学 2024-04-16 CN claimed
EP-0355460-A2 Stabilization of somatotropins by modification of cysteine residues utilizing site directed mutagenesis or chemical derivatization AMERICAN CYANAMID COMPANY (US) 1990-02-28 EP claimed
CN-119463756-A Binder, binder slurry, preparation method of binder slurry, current collector prime coating slurry and negative electrode plate 深圳市豪鹏科技股份有限公司 2025-02-18 CN disclosed
CN-117886999-A Preparation method and application of benzoxazine-olefin copolymer for deep well cementation 西南石油大学 2024-04-16 CN disclosed
US-11130737-B2 Multifunctional aminoquinoline therapeutic agents LOHOCLA RESEARCH CORPORATION (US) 2021-09-28 US disclosed
US-20200095204-A1 MULTIFUNCTIONAL AMINOQUINOLINE THERAPEUTIC AGENTS LOHOCLA RESEARCH CORPORATION 2020-03-26 US disclosed
US-10435371-B2 Multifunctional aminoquinoline therapeutic agent LOHOCLA RESEARCH CORPORATION (US) 2019-10-08 US disclosed
US-20190092731-A1 MULTIFUNCAIONAL AMINOQUINOLINE THERAPEUTIC AGENT LOHOCLA RESEARCH CORPORATION 2019-03-28 US disclosed
US-10112905-B2 Multifunctional aminoquinoline therapeutic agents LOHOCLA RESEARCH CORPORATION (US) 2018-10-30 US disclosed
US-20170204064-A1 MULTIFUNCTIONAL AMINOQUINOLINE THERAPEUTIC AGENTS LOHOCLA RESEARCH CORPORATION 2017-07-20 US disclosed
EP-3157523-A1 MULTIFUNCTIONAL AMINOQUINOLINE THERAPEUTIC AGENTS Lohocla Research Corporation (US) 2017-04-26 EP disclosed
WO-1999009145-A1 IDENTIFICATION OF SORTASE GENE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1999-02-25 WO disclosed
EP-0519039-A1 HUMAN bFGF DERIVATIVES, THEIR ANALOGS AND PROCESS FOR THEIR PRODUCTION PHARMACIA S.p.A. (IT) 1992-12-23 EP disclosed
WO-1992012245-A1 HUMAN BFGF DERIVATIVES, THEIR ANALOGS AND PROCESS FOR THEIR PRODUCTION FARMITALIA CARLO ERBA S.R.L. (IT) 1992-07-23 WO disclosed
EP-0494664-A1 Human bFGF derivatives, their analogs and process for their production FARMITALIA CARLO ERBA S.r.l. (IT) 1992-07-15 EP disclosed
US-4957912-A ANTIBIOTICS MERCK & CO., INC. (US) 1990-09-18 US disclosed
US-4656263-A 6-β-substituted penicillanic acid compound free of the 6-α-epimer PFIZER INC. (US) 1987-04-07 US disclosed
US-4518530-A 6-β-Substituted penicillanic acids as β-lactamase inhibitors PFIZER INC. (US) 1985-05-21 US disclosed
US-4517126-A Penicillanic acid derivative PFIZER INC. (US) 1985-05-14 US disclosed
US-4397783-A HYDRODEHALOGENATION WITH AN ORGANOTIN HYDRIDE PFIZER INC. (US) 1983-08-09 US disclosed